NEXGEL, Inc.
NXGLNASDAQHealthcareMedical Instruments & Supplies

About NEXGEL

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitenexgel.com
Phone215 702 8550
Address
2150 Cabot Boulevard West, Suite B Langhorne, Pennsylvania 19047 United States

Corporate Identifiers

CIK0001468929
CUSIP65344E107
ISINUS65344E1073
EIN26-4042544
SIC3841

Leadership Team & Key Executives

Adam R. Levy
Chief Executive Officer, President and Director
Joseph F. McGuire
Chief Financial Officer
Gregory J. Robb
Vice President of Operations